Our brief was to deliver the global professional promotional launch campaign for this genuine breakthrough for MS patients and their doctors, making it clear all around the world how transformative this drug will be for people with MS and those treating them.

A new drug, MAVENCLAD, provides a radically different, innovative but ultimately much simpler approach to managing MS with the same efficacy as existing therapies but requiring just 20 pills over a 5 year period, giving patients a holiday from MS and its treatment.

Currently, having MS makes life very complicated. The unpredictable, debilitating nature of the disease leaves people living on a knife edge, existing treatments are disruptive and problematic in their own right.

Treating MS is similarly complicated, existing options can be time-consuming to manage and monitor, HCPs are faced with a 'high-maintenance' patient population.

There is little opportunity for a 'normal' life. MAVENCLAD changes all that.

We worked with an award winning animation company based in London, to create a unique style and story. After immersing ourselves into the world of the art deco holiday posters, we identified the language to create something that would have had the same feeling but with a modern twist. The whole process took about two months going from script to final animation trough 3d modelling, coloring and lighting. The film was launched at an internal congress in Madrid and then localized by each launching country. It currently lives on the Sales Aid, Website, Banner Ads and it’s used in Congresses.